Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prostate cancer
Pharma
Novartis' Pluvicto unlocks substantial new patient pool
Novartis’ blockbuster radioligand therapy Pluvicto has cleared a key milestone on its quest to hit $5 billion in peak sales.
Fraiser Kansteiner
Aug 3, 2026 8:33am
Celcuity set to be Big Pharma 'strategic target' after approval
Jul 14, 2026 4:56pm
Novartis’ ‘Relax Your Tight End’ wins Cannes Pharma Grand Prix
Jun 23, 2026 9:06am
ASCO: J&J positions Erleada to shake up prostate cancer care
May 31, 2026 8:00am
ASCO: Pfizer one-ups J&J in prostate cancer
May 30, 2026 8:00am
Fierce Biotech
FDA flags concerns for AZ's camizestrant, Truqap ahead of adcomm
Apr 28, 2026 2:47pm
